|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4035 | |
| A61K 45/06 | |||
| A61K 9/00 | |||
| A61K 9/08 | |||
| A61K 9/20 | |||
| A61K 9/48 | |||
| A61K 47/02 | |||
| A61K 47/38 | |||
| A61K 47/44 | |||
| A61P 17/02 | |||
| A61P 17/10 | |||
| A61K 47/06 | |||
| A61K 47/10 | |||
| A61K 47/14 | |||
| A61K 47/26 | |||
| A61K 9/06 | |||
| A61K 9/70 |
| (11) | Patento numeris | 2683376 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12709437.3 |
| Europos patento paraiškos padavimo data | 2012-03-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-01-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/027368 |
| Data | 2012-03-02 |
| (87) | Numeris | WO 2012/121988 |
| Data | 2012-09-13 |
| (30) | Numeris | Data | Šalis |
| 201161449716 P | 2011-03-07 | US |
| (72) |
SCHAFER, Peter, H., US
SHANKAR, Sai, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | METHODS FOR TREATING DISEASES USING ISOINDOLINE COMPOUNDS |
| METHODS FOR TREATING DISEASES USING ISOINDOLINE COMPOUNDS |